15 results on '"Gjerdrum, Lise M. R."'
Search Results
2. Bone Involvement as a Primary Rare Manifestation of Waldenstrom Macroglobulinemia:A Case Report and Prevalence in a Nationwide Population-Based Cohort Study
- Author
-
Bhatti, Khazra, Nazir, Aqsa, Ostergaard, Simon, Schejbel, Lone, Norgaard, Peter, Gjerdrum, Lise M R, Moghaddas, Mahnaz, Nielsen, Torsten H, Munksgaard, Lars, Pedersen, Lars M, Bhatti, Khazra, Nazir, Aqsa, Ostergaard, Simon, Schejbel, Lone, Norgaard, Peter, Gjerdrum, Lise M R, Moghaddas, Mahnaz, Nielsen, Torsten H, Munksgaard, Lars, and Pedersen, Lars M
- Abstract
Bone involvement is a rare extranodal manifestation in patients with malignant lymphoproliferative diseases and has also been noted as a rare event in patients with Waldenstrom macroglobulinemia (WM). However, the actual prevalence has not been previously reported. We describe an unusual case of a patient with WM who presented with lower back pain and focal bone lesions at initial diagnosis. Magnetic resonance imaging (MRI) revealed multiple vertebral fractures. Positron emission tomography (PET) detected only nodal changes without pathological skeletal-related metabolic activity. Lymph node and bone marrow biopsies combined with an immunoglobulin M (IgM) M component revealed the diagnosis of WM. A next-generation sequencing (NGS) analysis using a targeted lymphoma panel of 59 recurrently mutated genes in lymphoid neoplasms showed mutations in the MYD88 and CD79B genes. After treatment with rituximab and bendamustine, the patient achieved a partial remission and pain relief. After 3 years of stable disease, a spontaneous subcapital fracture at the base of the femoral neck and new vertebral compression fractures occurred. Whole-body low-dose computed tomography (WB-LDCT) and bone density (dual energy X-ray absorptiometry (DEXA)) scan revealed marked osteopenia. After insertion of a hip prosthesis, examination of the removed hip showed infiltration of clonal lymphoplasmacytic cells. Our case confirms that one must be aware that bone involvement in patients with WM can occur as a rare manifestation. Interestingly, the MYD88/CD79B-mutated (MCD) genotype in diffuse large B-cell lymphoma is characterized by extranodal involvement and may also be involved in the pathogenesis of skeletal-related disease in the present case. As a follow-up to this unusual case, we have carried out an analysis based on the Danish Lymphoma Registry (LYFO) covering the entire national population in the period 2000 - 2020. The registry study included a cohort of 2,459 patients with WM and lympho, Bone involvement is a rare extranodal manifestation in patients with malignant lymphoproliferative diseases and has also been noted as a rare event in patients with Waldenstrom macroglobulinemia (WM). However, the actual prevalence has not been previously reported. We describe an unusual case of a patient with WM who presented with lower back pain and focal bone lesions at initial diagnosis. Magnetic resonance imaging (MRI) revealed multiple vertebral fractures. Positron emission tomography (PET) detected only nodal changes without pathological skeletal-related metabolic activity. Lymph node and bone marrow biopsies combined with an immunoglobulin M (IgM) M component revealed the diagnosis of WM. A next-generation sequencing (NGS) analysis using a targeted lymphoma panel of 59 recurrently mutated genes in lymphoid neoplasms showed mutations in the MYD88 and CD79B genes. After treatment with rituximab and bendamustine, the patient achieved a partial remission and pain relief. After 3 years of stable disease, a spontaneous subcapital fracture at the base of the femoral neck and new vertebral compression fractures occurred. Whole-body low-dose computed tomography (WB-LDCT) and bone density (dual energy X-ray absorptiometry (DEXA)) scan revealed marked osteopenia. After insertion of a hip prosthesis, examination of the removed hip showed infiltration of clonal lymphoplasmacytic cells. Our case confirms that one must be aware that bone involvement in patients with WM can occur as a rare manifestation. Interestingly, the MYD88/CD79B-mutated (MCD) genotype in diffuse large B-cell lymphoma is characterized by extranodal involvement and may also be involved in the pathogenesis of skeletal-related disease in the present case. As a follow-up to this unusual case, we have carried out an analysis based on the Danish Lymphoma Registry (LYFO) covering the entire national population in the period 2000 - 2020. The registry study included a cohort of 2,459 patients with WM and lym
- Published
- 2022
3. Antibiotics inhibit tumor and disease activity in cutaneous T cell lymphoma
- Author
-
Lindahl, Lise M, Willerslev-Olsen, Andreas, Gjerdrum, Lise M R, Nielsen, Pia R, Blümel, Edda, Rittig, Anne H, Celis, Pamela, Herpers, Bjorn, Becker, Jürgen C, Stausbøl-Grøn, Birgitte, Wasik, Mariusz A, Gluud, Maria, Fredholm, Simon, Buus, Terkild B, Johansen, Claus, Nastasi, Claudia, Peiffer, Lukas, Kubat, Linda, Bzorek, Michael, Eriksen, Jens O, Krejsgaard, Thorbjørn, Bonefeld, Charlotte M, Geisler, Carsten, Mustelin, Tomas, Langhoff, Erik, Givskov, Michael, Woetmann, Anders, Kilian, Mogens, Litman, Thomas, Iversen, Lars, Odum, Niels, Lindahl, Lise M, Willerslev-Olsen, Andreas, Gjerdrum, Lise M R, Nielsen, Pia R, Blümel, Edda, Rittig, Anne H, Celis, Pamela, Herpers, Bjorn, Becker, Jürgen C, Stausbøl-Grøn, Birgitte, Wasik, Mariusz A, Gluud, Maria, Fredholm, Simon, Buus, Terkild B, Johansen, Claus, Nastasi, Claudia, Peiffer, Lukas, Kubat, Linda, Bzorek, Michael, Eriksen, Jens O, Krejsgaard, Thorbjørn, Bonefeld, Charlotte M, Geisler, Carsten, Mustelin, Tomas, Langhoff, Erik, Givskov, Michael, Woetmann, Anders, Kilian, Mogens, Litman, Thomas, Iversen, Lars, and Odum, Niels
- Abstract
It has been proposed that CD4 T cell responses to Staphylococcus aureus (SA) can inadvertently enhance neoplastic progression in models of skin cancer and cutaneous T cell lymphoma (CTCL). In this prospective study, we explored the effect of transient antibiotic treatment on tumor cells and disease activity in eight patients with advanced stage CTCL. All patients experienced significant decrease in clinical symptoms in response to aggressive, transient antibiotic treatment. In some patients, clinical improvements lasted for more than 8 months. In six out of eight patients, a malignant T cell clone could be identified in lesional skin, and a significant decrease in the fraction of malignant T cells was observed following antibiotics but an otherwise unchanged treatment regimen. Immunohistochemistry, global mRNA expression, and cell-signaling pathway analysis indicated that transient aggressive antibiotic therapy was associated with decreased expression of IL-2 high-affinity receptors (CD25), STAT3 signaling, and cell proliferation in lesional skin. In conclusion, this study provides novel evidence suggesting that aggressive antibiotic treatment inhibits malignant T cells in lesional skin. Thus, we provide a novel rationale for treatment of SA in advanced CTCL.
- Published
- 2019
4. Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma
- Author
-
Lindahl, Lise M., primary, Willerslev-Olsen, Andreas, additional, Gjerdrum, Lise M. R., additional, Nielsen, Pia R., additional, Blümel, Edda, additional, Rittig, Anne H., additional, Celis, Pamela, additional, Herpers, Bjorn, additional, Becker, Jürgen C., additional, Stausbøl-Grøn, Birgitte, additional, Wasik, Mariusz A., additional, Gluud, Maria, additional, Fredholm, Simon, additional, Buus, Terkild B., additional, Johansen, Claus, additional, Nastasi, Claudia, additional, Peiffer, Lukas, additional, Kubat, Linda, additional, Bzorek, Michael, additional, Eriksen, Jens O., additional, Krejsgaard, Thorbjørn, additional, Bonefeld, Charlotte M., additional, Geisler, Carsten, additional, Mustelin, Tomas, additional, Langhoff, Erik, additional, Givskov, Michael, additional, Woetmann, Anders, additional, Kilian, Mogens, additional, Litman, Thomas, additional, Iversen, Lars, additional, and Odum, Niels, additional
- Published
- 2019
- Full Text
- View/download PDF
5. Prognostic miRNA classifier in early-stage mycosis fungoides:development and validation in a Danish nationwide study
- Author
-
Lindahl, Lise M, Besenbacher, Søren, Rittig, Anne H, Celis, Pamela, Willerslev-Olsen, Andreas, Gjerdrum, Lise M R, Krejsgaard, Thorbjørn, Johansen, Claus, Litman, Thomas, Woetmann, Anders, Odum, Niels, Iversen, Lars, Lindahl, Lise M, Besenbacher, Søren, Rittig, Anne H, Celis, Pamela, Willerslev-Olsen, Andreas, Gjerdrum, Lise M R, Krejsgaard, Thorbjørn, Johansen, Claus, Litman, Thomas, Woetmann, Anders, Odum, Niels, and Iversen, Lars
- Abstract
Mycosis fungoides (MF) is the most frequent form of cutaneous T-cell lymphoma. The disease often takes an indolent course, but in approximately one-third of the patients, the disease progresses to an aggressive malignancy with a poor prognosis. At the time of diagnosis, it is impossible to predict which patients develop severe disease and are in need of aggressive treatment. Accordingly, we investigated the prognostic potential of microRNAs (miRNAs) at the time of diagnosis in MF. Using a quantitative reverse transcription polymerase chain reaction platform, we analyzed miRNA expression in diagnostic skin biopsies from 154 Danish patients with early-stage MF. The patients were subdivided into a discovery cohort (n = 82) and an independent validation cohort (n = 72). The miRNA classifier was built using a LASSO (least absolute shrinkage and selection operator) Cox regression to predict progression-free survival (PFS). We developed a 3-miRNA classifier, based on miR-106b-5p, miR-148a-3p, and miR-338-3p, which successfully separated patients into high-risk and low-risk groups of disease progression. PFS was significantly different between these groups in both the discovery cohort and the validation cohort. The classifier was stronger than existing clinical prognostic factors and remained a strong independent prognostic tool after stratification and adjustment for these factors. Importantly, patients in the high-risk group had a significantly reduced overall survival. The 3-miRNA classifier is an effective tool to predict disease progression of early-stage MF at the time of diagnosis. The classifier adds significant prognostic value to existing clinical prognostic factors and may facilitate more individualized treatment of these patients.
- Published
- 2018
6. Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study
- Author
-
Lindahl, Lise M., primary, Besenbacher, Søren, additional, Rittig, Anne H., additional, Celis, Pamela, additional, Willerslev-Olsen, Andreas, additional, Gjerdrum, Lise M. R., additional, Krejsgaard, Thorbjørn, additional, Johansen, Claus, additional, Litman, Thomas, additional, Woetmann, Anders, additional, Odum, Niels, additional, and Iversen, Lars, additional
- Published
- 2018
- Full Text
- View/download PDF
7. Immunosuppressive Environment in Basal Cell Carcinoma:The Role of Regulatory T Cells
- Author
-
Omland, Silje Haukali, Nielsen, Patricia S, Gjerdrum, Lise M R, Gniadecki, Robert, Omland, Silje Haukali, Nielsen, Patricia S, Gjerdrum, Lise M R, and Gniadecki, Robert
- Abstract
Interaction between tumour survival tactics and anti-tumour immune response is a major determinant for cancer growth. Regulatory T cells (T-regs) contribute to tumour immune escape, but their role in basal cell carcinoma (BCC) is not understood. The fraction of T-regs among T cells was analysed by immunohistochemistry followed by automated image analysis in facial BCC, peritumoural skin and normal, buttock skin. Quantitative real-time PCR (qRT-PCR) was performed for FOXP3 and cytokines involved in T-reg attraction and T-cell activation. T-regs comprised 45% of CD4-cells surrounding BCC. FOXP3 was highly expressed in BCC, but absent in buttock skin. Unexpectedly, expression of FOXP3 was increased in peritumoural skin, with the FOXP3/CD3 fractions exceeding those of BCC (p?=?0.0065). Transforming growth factor (TGF)-? and T-reg chemokine expression was increased in BCC and peritumoural skin, but not in buttock skin, with expression levels correlating with FOXP3. T-regs are abundantly present both in BCC and in peritumoural skin, mediating an immunosuppressed microenvironment permissive for skin cancer.
- Published
- 2016
8. Immunoregulatory T Cells May Be Involved in Preserving CD4 T Cell Counts in HIV-Infected Long-Term Nonprogressors and Controllers
- Author
-
Gaardbo, Julie C, Ronit, Andreas, Hartling, Hans J, Gjerdrum, Lise M R, Springborg, Karoline, Ralfkiær, Elisabeth, Thorsteinsson, Kristina, Ullum, Henrik, Andersen, Åse B, Nielsen, Susanne D, Gaardbo, Julie C, Ronit, Andreas, Hartling, Hans J, Gjerdrum, Lise M R, Springborg, Karoline, Ralfkiær, Elisabeth, Thorsteinsson, Kristina, Ullum, Henrik, Andersen, Åse B, and Nielsen, Susanne D
- Abstract
BACKGROUND: HIV-infected controllers control viral replication and maintain normal CD4 T cell counts. Long-term nonprogressors (LTNPs) also maintain normal CD4 T cell counts but have ongoing viral replication. We hypothesized that immunoregulatory mechanisms are involved in preserved CD4 T cell counts in controllers and in LTNPs.METHODS: Twenty HIV-infected viremic controllers, 5 elite controllers (ECs), and 14 LTNPs were included in this cross-sectional study. For comparison, 25 progressors and 34 healthy controls were included. Regulatory T cells (Tregs), Treg subpopulations, CD161+Th17 cells, and CD3+CD8+CD161(high)Tc17 cells in peripheral blood were measured using flow cytometry. Tregs in lymphoid tissue were determined in tonsil biopsies and evaluated using immunolabeling. The production of transforming growth factor beta (TGF-β), interleukin (IL)-10, and IL-17 upon stimulation with phytohemagglutinin in peripheral blood was determined by Luminex.RESULTS: All groups of HIV-infected patients displayed similar percentages of Tregs in both peripheral blood and lymphoid tissue. However, a larger percentage of Tregs in ECs and LTNPs were activated compared with that in controls, progressors, and viremic controllers. Further, ECs as the only group of HIV-infected patients, displayed elevated percentages of CD161+Th17 cells, preserved CD3+CD8+CD161(high)Tc17 cells, and preserved IL-10 production.CONCLUSIONS: Overall, Treg percentage was similar in both blood and lymphoid tissue in all groups of patients and controls. However, both ECs and LTNPs displayed a large proportion of activated Tregs suggesting immunoregulatory mechanisms to be involved in preserving CD4 T cell counts in HIV-infected nonprogressors.
- Published
- 2014
9. Regulatory T Cells in HIV-Infected Immunological Nonresponders Are Increased in Blood but Depleted in Lymphoid Tissue and Predict Immunological Reconstitution
- Author
-
Gaardbo, Julie C, Hartling, Hans J, Ronit, Andreas, Springborg, Karoline, Gjerdrum, Lise M R, Ralfkiær, Elisabeth, Thorsteinsson, Kristina, Ullum, Henrik, Andersen, Åse B, Nielsen, Susanne D, Gaardbo, Julie C, Hartling, Hans J, Ronit, Andreas, Springborg, Karoline, Gjerdrum, Lise M R, Ralfkiær, Elisabeth, Thorsteinsson, Kristina, Ullum, Henrik, Andersen, Åse B, and Nielsen, Susanne D
- Abstract
BACKGROUND: HIV-infected immunological nonresponders fail to immune reconstitute despite optimal treatment. We hypothesized that regulatory T cells (Tregs) are involved in immunological reconstitution. Tregs and Treg subpopulations were measured in blood and Foxp3 cells in lymphoid tissue, and the impact of Tregs on immunological reconstitution was determined.METHODS: HIV-infected individuals on combination antiretroviral therapy for a minimum of 2 years were included. The study population included 14 immunological nonresponders (INR; CD4 T-cell count <200 cells/μL), 33 intermediate responders (CD4 T-cell count 200-500 cells/μL), 30 responders (CD4 T-cell count >500 cells/μL), and 34 healthy controls. Tregs, Treg subpopulations, and intracellular staining for interleukin 10 in peripheral blood were measured using flow cytometry. Foxp3 cells in lymphoid tissue were evaluated using immunolabeling. The CD4 T-cell count was determined at inclusion and after 1 year of follow-up.RESULTS: INR displayed high percentage of Tregs and activated Tregs in peripheral blood accompanied by a high percentage of Tregs expressing interleukin 10, whereas numbers of Foxp3 cells in lymphoid tissue were low. In contrast, responders resembled healthy controls. Finally, in INR, high level of Tregs in blood and Foxp3 cells in lymphoid tissue were associated with higher level of immunological reconstitution after 1 year of follow-up.CONCLUSIONS: In conclusion, altered distribution of Tregs was found in INR. Interestingly, high level of Tregs predicted higher level of immunological reconstitution suggesting a role for Tregs in immunological reconstitution.
- Published
- 2014
10. Immunosuppressive Environment in Basal Cell Carcinoma: The Role of Regulatory T Cells.
- Author
-
OMLAND, Silje H., NIELSEN, Patricia S., GJERDRUM, Lise M. R., and GNIADECKI, Robert
- Subjects
BASAL cell carcinoma ,T cells ,IMMUNE response ,TUMOR growth ,IMMUNOHISTOCHEMISTRY ,CD4 antigen ,CHEMOKINES - Abstract
Interaction between tumour survival tactics and antitumour immune response is a major determinant for cancer growth. Regulatory T cells (T-regs) contribute to tumour immune escape, but their role in basal cell carcinoma (BCC) is not understood. The fraction of T-regs among T cells was analysed by immunohistochemistry followed by automated image analysis in facial BCC, peritumoural skin and normal, buttock skin. Quantitative real-time PCR (qRT-PCR) was performed for FOXP3 and cytokines involved in T-reg attraction and T-cell activation. T-regs comprised 45% of CD4-cells surrounding BCC. FOXP3 was highly expressed in BCC, but absent in buttock skin. Unexpectedly, expression of FOXP3 was increased in peritumoural skin, with the FOXP3/CD3 fractions exceeding those of BCC (p = 0.0065). Transforming growth factor (TGF)-β and T-reg chemokine expression was increased in BCC and peritumoural skin, but not in buttock skin, with expression levels correlating with FOXP3 . T-regs are abundantly present both in BCC and in peritumoural skin, mediating an immunosuppressed microenvironment permissive for skin cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
11. Regulatory T Cells in HIV-Infected Immunological Nonresponders Are Increased in Blood but Depleted in Lymphoid Tissue and Predict Immunological Reconstitution
- Author
-
Gaardbo, Julie C., primary, Hartling, Hans J., additional, Ronit, Andreas, additional, Springborg, Karoline, additional, Gjerdrum, Lise M. R., additional, Ralfkiær, Elisabeth, additional, Thorsteinsson, Kristina, additional, Ullum, Henrik, additional, Andersen, Åse B., additional, and Nielsen, Susanne D., additional
- Published
- 2014
- Full Text
- View/download PDF
12. Immunoregulatory T Cells May Be Involved in Preserving CD4 T Cell Counts in HIV-Infected Long-Term Nonprogressors and Controllers
- Author
-
Gaardbo, Julie C., primary, Ronit, Andreas, additional, Hartling, Hans J., additional, Gjerdrum, Lise M. R., additional, Springborg, Karoline, additional, Ralfkiær, Elisabeth, additional, Thorsteinsson, Kristina, additional, Ullum, Henrik, additional, Andersen, Åse B., additional, and Nielsen, Susanne D., additional
- Published
- 2014
- Full Text
- View/download PDF
13. Bone Involvement as a Primary Rare Manifestation of Waldenstrom Macroglobulinemia: A Case Report and Prevalence in a Nationwide Population-Based Cohort Study.
- Author
-
Bhatti K, Nazir A, Ostergaard S, Schejbel L, Norgaard P, Gjerdrum LMR, Moghaddas M, Nielsen TH, Munksgaard L, and Pedersen LM
- Abstract
Bone involvement is a rare extranodal manifestation in patients with malignant lymphoproliferative diseases and has also been noted as a rare event in patients with Waldenstrom macroglobulinemia (WM). However, the actual prevalence has not been previously reported. We describe an unusual case of a patient with WM who presented with lower back pain and focal bone lesions at initial diagnosis. Magnetic resonance imaging (MRI) revealed multiple vertebral fractures. Positron emission tomography (PET) detected only nodal changes without pathological skeletal-related metabolic activity. Lymph node and bone marrow biopsies combined with an immunoglobulin M (IgM) M component revealed the diagnosis of WM. A next-generation sequencing (NGS) analysis using a targeted lymphoma panel of 59 recurrently mutated genes in lymphoid neoplasms showed mutations in the MYD88 and CD79B genes. After treatment with rituximab and bendamustine, the patient achieved a partial remission and pain relief. After 3 years of stable disease, a spontaneous subcapital fracture at the base of the femoral neck and new vertebral compression fractures occurred. Whole-body low-dose computed tomography (WB-LDCT) and bone density (dual energy X-ray absorptiometry (DEXA)) scan revealed marked osteopenia. After insertion of a hip prosthesis, examination of the removed hip showed infiltration of clonal lymphoplasmacytic cells. Our case confirms that one must be aware that bone involvement in patients with WM can occur as a rare manifestation. Interestingly, the MYD88/CD79B -mutated (MCD) genotype in diffuse large B-cell lymphoma is characterized by extranodal involvement and may also be involved in the pathogenesis of skeletal-related disease in the present case. As a follow-up to this unusual case, we have carried out an analysis based on the Danish Lymphoma Registry (LYFO) covering the entire national population in the period 2000 - 2020. The registry study included a cohort of 2,459 patients with WM and lymphoplasmacytic lymphoma. Our data revealed that primary bone involvement at diagnosis occurs in 1.75% of adults with WM. To the best of our knowledge, this is the first report of the prevalence of skeletal-related disease in a large nationwide cohort and defines bone involvement as an exceedingly rare event in WM., Competing Interests: The authors have no conflict of interest to declare., (Copyright 2022, Bhatti et al.)
- Published
- 2022
- Full Text
- View/download PDF
14. Regulatory T cells in HIV-infected immunological nonresponders are increased in blood but depleted in lymphoid tissue and predict immunological reconstitution.
- Author
-
Gaardbo JC, Hartling HJ, Ronit A, Springborg K, Gjerdrum LM, Ralfkiær E, Thorsteinsson K, Ullum H, Andersen ÅB, and Nielsen SD
- Subjects
- Adult, Aged, CD4 Lymphocyte Count, Case-Control Studies, Female, Forkhead Transcription Factors genetics, Forkhead Transcription Factors metabolism, Gene Expression Regulation immunology, Humans, Interleukin-10 genetics, Interleukin-10 metabolism, Male, Middle Aged, Anti-HIV Agents therapeutic use, HIV Infections drug therapy, HIV Infections immunology, Lymphoid Tissue cytology, T-Lymphocytes, Regulatory physiology
- Abstract
Background: HIV-infected immunological nonresponders fail to immune reconstitute despite optimal treatment. We hypothesized that regulatory T cells (Tregs) are involved in immunological reconstitution. Tregs and Treg subpopulations were measured in blood and Foxp3 cells in lymphoid tissue, and the impact of Tregs on immunological reconstitution was determined., Methods: HIV-infected individuals on combination antiretroviral therapy for a minimum of 2 years were included. The study population included 14 immunological nonresponders (INR; CD4 T-cell count <200 cells/μL), 33 intermediate responders (CD4 T-cell count 200-500 cells/μL), 30 responders (CD4 T-cell count >500 cells/μL), and 34 healthy controls. Tregs, Treg subpopulations, and intracellular staining for interleukin 10 in peripheral blood were measured using flow cytometry. Foxp3 cells in lymphoid tissue were evaluated using immunolabeling. The CD4 T-cell count was determined at inclusion and after 1 year of follow-up., Results: INR displayed high percentage of Tregs and activated Tregs in peripheral blood accompanied by a high percentage of Tregs expressing interleukin 10, whereas numbers of Foxp3 cells in lymphoid tissue were low. In contrast, responders resembled healthy controls. Finally, in INR, high level of Tregs in blood and Foxp3 cells in lymphoid tissue were associated with higher level of immunological reconstitution after 1 year of follow-up., Conclusions: In conclusion, altered distribution of Tregs was found in INR. Interestingly, high level of Tregs predicted higher level of immunological reconstitution suggesting a role for Tregs in immunological reconstitution.
- Published
- 2014
- Full Text
- View/download PDF
15. Immunoregulatory T cells may be involved in preserving CD4 T cell counts in HIV-infected long-term nonprogressors and controllers.
- Author
-
Gaardbo JC, Ronit A, Hartling HJ, Gjerdrum LM, Springborg K, Ralfkiær E, Thorsteinsson K, Ullum H, Andersen ÅB, and Nielsen SD
- Subjects
- Adult, CD3 Complex immunology, CD8-Positive T-Lymphocytes immunology, CD8-Positive T-Lymphocytes physiology, Case-Control Studies, Cross-Sectional Studies, Female, Flow Cytometry, Humans, Interleukin-10 blood, Interleukin-17 blood, Lymphocyte Subsets immunology, Lymphocyte Subsets physiology, Male, Middle Aged, NK Cell Lectin-Like Receptor Subfamily B immunology, T-Lymphocytes, Regulatory immunology, Th17 Cells immunology, Th17 Cells physiology, Transforming Growth Factor beta blood, CD4 Lymphocyte Count, HIV Infections immunology, HIV Long-Term Survivors, T-Lymphocytes, Regulatory physiology
- Abstract
Background: HIV-infected controllers control viral replication and maintain normal CD4 T cell counts. Long-term nonprogressors (LTNPs) also maintain normal CD4 T cell counts but have ongoing viral replication. We hypothesized that immunoregulatory mechanisms are involved in preserved CD4 T cell counts in controllers and in LTNPs., Methods: Twenty HIV-infected viremic controllers, 5 elite controllers (ECs), and 14 LTNPs were included in this cross-sectional study. For comparison, 25 progressors and 34 healthy controls were included. Regulatory T cells (Tregs), Treg subpopulations, CD161+Th17 cells, and CD3+CD8+CD161(high)Tc17 cells in peripheral blood were measured using flow cytometry. Tregs in lymphoid tissue were determined in tonsil biopsies and evaluated using immunolabeling. The production of transforming growth factor beta (TGF-β), interleukin (IL)-10, and IL-17 upon stimulation with phytohemagglutinin in peripheral blood was determined by Luminex., Results: All groups of HIV-infected patients displayed similar percentages of Tregs in both peripheral blood and lymphoid tissue. However, a larger percentage of Tregs in ECs and LTNPs were activated compared with that in controls, progressors, and viremic controllers. Further, ECs as the only group of HIV-infected patients, displayed elevated percentages of CD161+Th17 cells, preserved CD3+CD8+CD161(high)Tc17 cells, and preserved IL-10 production., Conclusions: Overall, Treg percentage was similar in both blood and lymphoid tissue in all groups of patients and controls. However, both ECs and LTNPs displayed a large proportion of activated Tregs suggesting immunoregulatory mechanisms to be involved in preserving CD4 T cell counts in HIV-infected nonprogressors.
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.